Dr Melissa Byrne has spent more than 15 years in the life sciences industry, with her expertise and experience spanning cardiovascular physiology, medical research, research translation, and commercialisation.
A cardiovascular physiologist with commercial and academic experience, Melissa is passionate about taking research from the lab to the clinic. Prior to joining Brandon Capital, Melissa managed pre-clinical research at the Baker Heart Institute in Melbourne, where she was responsible for leading studies in animal models to prepare technologies for clinical development. There, Melissa conducted preclinical research trials for sponsors developing medical devices and therapeutics. The pre-clinical developmental and safety trials, including first-in-man studies that Melissa has completed and been involved in, have been pivotal for both the commercialisation and transfer of knowledge for a number of cardiovascular devices for use in the clinical setting. As a consequence she has been a named inventor on four US patent filings.
Melissa was awarded a Guidant Industry Fellowship as part of an NIH Program Grant focused on improved targeting of patients for CRT therapy at Johns Hopkins Medicine, Baltimore, USA.
She has held roles for both Research & Development and Clinical Operations for a number of biotech start up companies.
Melissa has a Bachelor of Science (Honours) from The University of Melbourne, a PhD in Cardiovascular Physiology from Monash University and a Graduate Certificate, Research Commercialisation from RMIT University.